tiprankstipranks
J&J report ‘not alarming’ for Legend Biotech, says H.C. Wainwright
PremiumThe FlyJ&J report ‘not alarming’ for Legend Biotech, says H.C. Wainwright
4d ago
Johnson & Johnson says no change to M&A strategy
PremiumThe Fly
Johnson & Johnson says no change to M&A strategy
4d ago
Johnson & Johnson says ‘off to solid financial start’ in 2024
PremiumThe Fly
Johnson & Johnson says ‘off to solid financial start’ in 2024
4d ago
Johnson & Johnson raises quarterly dividend 4.2% to $1.24 from $1.19 per share
PremiumThe FlyJohnson & Johnson raises quarterly dividend 4.2% to $1.24 from $1.19 per share
4d ago
Johnson & Johnson revises FY24 adjusted EPS to $10.60-$10.75 from $10.55-$10.75
PremiumThe Fly
Johnson & Johnson revises FY24 adjusted EPS to $10.60-$10.75 from $10.55-$10.75
4d ago
Johnson & Johnson reports Q1 adjusted EPS $2.71, consensus $2.64
PremiumThe Fly
Johnson & Johnson reports Q1 adjusted EPS $2.71, consensus $2.64
4d ago
Mind Medicine initiated with an Outperform at Leerink
PremiumThe FlyMind Medicine initiated with an Outperform at Leerink
5d ago
Integer upgraded to Buy from Neutral at BofA
PremiumThe Fly
Integer upgraded to Buy from Neutral at BofA
5d ago
JNJ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
JNJ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100